comprehensive -WSS

comprehensive

author：entertainment 2025-10-03 00:22:45 - browse：22

Senator Ron Wyden (D-OR) speaks with reporters in the Senate subway at the U.S. Capitol — Sen. Ron Wyden (D-Ore.) Drew Angerer/Getty Images

Senate Finance Committee members from both parties took aim Wednesday at insurance brokers that sell plans for large Medicare Advantage insurers.

Older adults at times have more than 100 plan options, and brokers help them choose the right one. But brokers can be incentivized by large insurance companies to aggressively sell plans that are a poor fit for the Medicare beneficiaries they’re supposed to help. Brokers also sometimes collect private information that they sell to multiple insurance companies. Those brokers tend to have a national scope, just like the large insurers they represent, compared to the independent, local brokers.

“They are big private marketing companies in the middle between seniors and their coverage,” Chairman Ron Wyden (D-Ore.) said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： The EPA's new lead rule: How one expert crunched the numbers

explore

WSS

FDA endorses new sterilization method for medical devices

J&J to emphasize cancer drugs, stop much of its vaccine research

With clinical trial data readouts, here's how to spot spin

Dog Aging Project founders on what lies ahead after losing funding

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

BIO selects John Crowley as new CEO

Wikipedia

comprehensive

focus

Virginia high school admissions case could be legal follow

Flagship Pioneering launches a new biotech in two countries

Dobbs anniversary: the lost opportunity of abortion as health care

Organ aging and disease risk measured by new blood test

Drug repurposing or repositioning? The language matters

With clinical trial data readouts, here's how to spot spin

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Walensky prepares to leave CDC — and Congress — behind

CVS is on a mission to consolidate health care. Will it work?

knowledge

Despite FDA concern, risk that CAR

Mayo Clinic plans $5B tech

High breast density mammograms need follow

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Disappointing trial forces Pfizer to pivot on obesity medicine plans

HPV vaccine, cervical cancer study delivers historic results

explore

explore

hotspot

hotspot